• Home
  • EMCrit-RACC
  • PulmCrit
  • IBCC
  • EMNerd
  • Tox & Hound
  • About
    • About EMCrit
    • About PulmCrit
    • EMCrit FAQ
    • Subscription Options
  • Contact Us

PulmCrit (EMCrit)

Online Medical Education on Emergency Department (ED) Critical Care, Trauma, and Resuscitation

  • About PulmCrit
  • Genius General Hospital
  • PulmCrit TOC
  • IBCC TOC
  • IBCC Podcast
You are here: Home / Archives for PULMCrit

PulmCrit – Baricitinib for COVID-19: The rise of the jakinibs

December 31, 2020 by Josh Farkas 4 Comments

Background:  JAK-inhibitors (jakinibs) in the greater context Much of the harm from infections is mediated by hyperactive inflammatory reactions.  To date, most research has focused on two classes of medications to treat this: Corticosteroids have the advantage of being cheap, widely available, and often effective.  The disadvantage is that corticosteroids modulate innumerable molecular pathways, thereby […]

PulmCrit – Dismantling the systemic racism of pulse oximetry

December 21, 2020 by Josh Farkas 8 Comments

Oximetry is fundamental to critical care.  Consequently, even small biases in pulse oximetry measurements could have real clinical impact (especially when leveraged across innumerable measurements among thousands of patients).    Racial bias in pulse oximetry was the subject of two studies in 2005 and 2007.  The topic was then largely ignored over the past 13 years.  […]

PulmCrit – I’m upset about the RELAX trial

December 14, 2020 by Josh Farkas 2 Comments

Some studies have reported a gradual upwards trend in the PEEP being used for intubated patients without ARDS (e.g., from 5 cm to 7 cm). Is this good or bad? That is the question which the RELAX trial embarked upon answering. It’s a complex question which probably doesn’t have a binary answer… but never mind – let’s get to the study.

IBCC chapter & cast – Massive Transfusion Protocol (MTP)

December 7, 2020 by Josh Farkas 3 Comments

Massive Transfusion Protocols have attracted substantial attention over the past several years, so most folks will be familiar with the general concepts.  This chapter reviews a variety of details which may be essential to the success of an MTP – yet can easily get lost in the chaos. The IBCC chapter is located 👉 here. […]

PulmCrit – Does Remdesivir reduce length of stay? SOLIDARITY vs. ACTT-1.

December 3, 2020 by Josh Farkas 6 Comments

With the publication of the SOLIDARITY trial, there is increasing consensus that remdesivir doesn’t affect mortality.  However, there continues to be debate about whether remdesivir affects hospital length of stay.  Let’s dig into the data here to try to reconcile differences between ACTT-1 and SOLIDARITY.  Did ACTT-1 actually show that remdesivir reduces the hospital length […]

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 80
  • Next Page »

Follow EMCrit Everywhere

Click for More Subscribe Options


Other Stuff

  • Have a great idea for the next podcast? Share it here!
  • Tough Questions. Maybe you have an answer!
  • When you're done listening to the podcast,
    check out these great sites.

Who We Are

We are the EMCrit Project, a team of independent medical bloggers and podcasters joined together by our common love of cutting-edge care, iconoclastic ramblings, and FOAM.

Like Us on Facebook

Like Us on Facebook

Subscribe by Email

EMCrit is a trademark of Metasin LLC. Copyright 2009-. This site represents our opinions only. See our full disclaimer, our privacy policy, commenting policy and here for credits and attribution.